
BiotechTV - News ASCO 2025: The leaders of Daiichi-Sankyo discuss new data for the ADC ENHERTU in 1L HER2+ breast cancer and 2L HER2+ gastric cancer, plus new targets that are emerging
Jun 2, 2025
Chapters
Transcript
Episode notes

BiotechTV - News